NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Anixa Biosciences Inc (NASDAQ: ANIX)

 
ANIX Technical Analysis
2
As on 9th Jun 2023 ANIX STOCK Price closed @ 3.42 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.63 & Strong Buy for SHORT-TERM with Stoploss of 3.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ANIXSTOCK Price

Open 3.48 Change Price %
High 3.51 1 Day -0.08 -2.29
Low 3.35 1 Week 0.20 6.21
Close 3.42 1 Month -1.20 -25.97
Volume 29742 1 Year 0.22 6.88
52 Week High 6.15 | 52 Week Low 2.50
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ANIX
Daily Charts
ANIX
Intraday Charts
Whats New @
Bazaartrend
ANIX
Free Analysis
 
ANIX Important Levels Intraday
RESISTANCE3.73
RESISTANCE3.63
RESISTANCE3.57
RESISTANCE3.51
SUPPORT3.33
SUPPORT3.27
SUPPORT3.21
SUPPORT3.11
 
ANIX Forecast April 2024
4th UP Forecast5.12
3rd UP Forecast4.57
2nd UP Forecast4.24
1st UP Forecast3.9
1st DOWN Forecast2.94
2nd DOWN Forecast2.6
3rd DOWN Forecast2.27
4th DOWN Forecast1.72
 
ANIX Weekly Forecast
4th UP Forecast4.54
3rd UP Forecast4.18
2nd UP Forecast3.96
1st UP Forecast3.74
1st DOWN Forecast3.10
2nd DOWN Forecast2.88
3rd DOWN Forecast2.66
4th DOWN Forecast2.30
 
ANIX Forecast2024
4th UP Forecast11.42
3rd UP Forecast8.85
2nd UP Forecast7.27
1st UP Forecast5.68
1st DOWN Forecast1.16
2nd DOWN Forecast-0.43
3rd DOWN Forecast-2.01
4th DOWN Forecast-4.58
 
 
ANIX Other Details
Segment EQ
Market Capital 143759520.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
ANIX Address
ANIX
 
ANIX Latest News
 
Your Comments and Response on Anixa Biosciences Inc
 
ANIX Business Profile
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California. Address: 3150 Almaden Expressway, San Jose, CA, United States, 95118
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service